Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New screenshot shows the same Study Details page with minor layout and styling changes; core study information such as eligibility criteria, locations, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:10:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T09:55:44.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:11:09.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version updated to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:58:43.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:31:15.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to renal cell carcinoma and various biological factors. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    9%
    Check dated 2025-08-30T11:16:47.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.